chr7-157201795-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014671.3(UBE3C):c.1406G>A(p.Arg469Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,610,790 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00080 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 2 hom. )
Consequence
UBE3C
NM_014671.3 missense
NM_014671.3 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 3.10
Genes affected
UBE3C (HGNC:16803): (ubiquitin protein ligase E3C) Enables ubiquitin protein ligase activity. Involved in protein polyubiquitination. Predicted to be located in nucleus. Predicted to be part of proteasome complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.019501).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE3C | NM_014671.3 | c.1406G>A | p.Arg469Gln | missense_variant | 11/23 | ENST00000348165.10 | NP_055486.2 | |
UBE3C | XM_047421072.1 | c.1343G>A | p.Arg448Gln | missense_variant | 11/23 | XP_047277028.1 | ||
UBE3C | XM_005249564.5 | c.1331G>A | p.Arg444Gln | missense_variant | 10/22 | XP_005249621.1 | ||
UBE3C | XM_047421073.1 | c.1406G>A | p.Arg469Gln | missense_variant | 11/16 | XP_047277029.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE3C | ENST00000348165.10 | c.1406G>A | p.Arg469Gln | missense_variant | 11/23 | 1 | NM_014671.3 | ENSP00000309198 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000803 AC: 122AN: 151850Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
122
AN:
151850
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000722 AC: 180AN: 249260Hom.: 0 AF XY: 0.000727 AC XY: 98AN XY: 134868
GnomAD3 exomes
AF:
AC:
180
AN:
249260
Hom.:
AF XY:
AC XY:
98
AN XY:
134868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00109 AC: 1589AN: 1458822Hom.: 2 Cov.: 31 AF XY: 0.00107 AC XY: 777AN XY: 725832
GnomAD4 exome
AF:
AC:
1589
AN:
1458822
Hom.:
Cov.:
31
AF XY:
AC XY:
777
AN XY:
725832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000803 AC: 122AN: 151968Hom.: 0 Cov.: 31 AF XY: 0.000565 AC XY: 42AN XY: 74280
GnomAD4 genome
AF:
AC:
122
AN:
151968
Hom.:
Cov.:
31
AF XY:
AC XY:
42
AN XY:
74280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
14
ExAC
AF:
AC:
82
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1406G>A (p.R469Q) alteration is located in exon 11 (coding exon 11) of the UBE3C gene. This alteration results from a G to A substitution at nucleotide position 1406, causing the arginine (R) at amino acid position 469 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at